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The injurious consequences of ionizing radiation (IR) to normal human cells and the acquired radioresistance of cancer cells
represent limitations to cancer radiotherapy. IR induces DNA damage response pathways that orchestrate cell cycle arrest, DNA
repair or apoptosis such that irradiated cells are either repaired or eliminated. Concomitantly and independent of DNA damage,
IR activates acid sphingomyelinase (ASMase), which generates ceramide, thereby promoting radiation-induced apoptosis.
However, ceramide can also be metabolized to sphingosine-1-phosphate (S1P), which acts paradoxically as a radioprotectant.
Thus, sphingolipid metabolism represents a radiosensitivity pivot point, a notion supported by genetic evidence in IR-resistant
cancer cells. S1P lyase (SPL) catalyzes the irreversible degradation of S1P inthe ﬁnal step ofsphingolipid metabolism.We show
that SPL modulates the kinetics of DNA repair, speed of recovery from G2 cell cycle arrest and the extent of apoptosis after IR.
SPL acts through a novel feedback mechanism that ampliﬁes stress-induced ceramide accumulation, and downregulation/
inhibition of either SPL or ASMase prevents premature cell cycle progression and mitotic death. Further, oral administration of
an SPL inhibitor to mice prolonged their survival after exposure to a lethal dose of total body IR. Our ﬁndings reveal SPL to be a
regulator of ASMase, the G2 checkpoint and DNA repair and a novel target for radioprotection.
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The genomic integrity of eukaryotic cells is maintained by a
DNA damage response (DDR) that includes DNA repair
mechanisms combined with cell cycle checkpoints.
1 The G2
checkpoint is activated by double-stranded breaks or a region
of single-stranded DNA caused by chemical agents, ionizing
radiation (IR) or stalled replication forks generated during
S phase. Progression from the G2 phase to mitosis is
mediated by the cyclin-dependent kinase 1 (Cdk1)–cyclin B
complex. This complex is activated late in G2, driving the cell
into mitosis. In the presence of DNA damage, DNA repair
mechanisms are activated and the Cdk1–cyclin B complex is
held in check, thereby initiating the G2 checkpoint. If the
extentof DNA damage overwhelms the capability of the repair
machinery, the DDR induces signaling pathways resulting in
apoptosis. Although much is known regarding the signaling
events that converge on the DDR, molecular events involved
in initiation, maintenance, adaptation and reversal of the G2
checkpoint and the Cdk1–cyclin B complex have not been
fully elucidated.
2
Sphingolipid metabolites are ubiquitous regulators of the
cellular response to stress. Ceramide is a sphingolipid
metabolite that accumulates in irradiated cells and the serum
of irradiated patients.
3–6 This is due largely to the radiation-
induced hydrolysis of sphingomyelin (SM) by sphingomyeli-
nases (SMases) that are activated immediately after IR
exposure independently of DNA damage.
6–8 Ceramide
disrupts membrane rafts, induces apoptotic signaling cas-
cades and contributestoepithelial and endothelial cell death.
9
Inhibition of ceramide formation has been proposed as a
method to prevent radiation-induced cell and tissue injury.
Reducing ceramide accumulation by blocking SMase or
through genetic deletion of the acid sphingomyelinase
(ASMase) gene SMPD1 attenuates IR injury in rodent
models.
10,11
Ceramide can be further metabolized to sphingosine-1-
phosphate (S1P) via formation of the biochemical intermedi-
ate, sphingosine. S1P is a bioactive lipid that acts through
both receptor-mediated and intracellular signaling mechan-
isms to promote cell proliferation and survival and block
apoptosis.
12 S1P acts as a radioprotectant, preventing oocyte
apoptosis and sterility in irradiated mice.
13,14 S1P is irrever-
sibly degraded by the intracellular enzyme, S1P lyase
(SPL).
15 SPL is induced by DNA damage and other stressful
conditions.
16 Increased expression and activity of SPL
promote apoptosis, whereas inhibiting SPL in cells reduces
apoptosis in response to genotoxic and other stresses.
16–19
Inthisstudy,weinvestigatedtheeffectofIRonSPLandthe
role of SPL in mediating the DDR. We show that SPL is a
radiation-responsive protein whose expression regulates
maintenance of the G2 checkpoint and radiation-induced
apoptosis through a mechanism involving both S1P and
ceramide. Our ﬁndings establish the existence of a novel
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Results
SPL is a radioresponsive protein that potentiates cell
death after IR. To determine whether IR inﬂuences SPL
expression, we subjected human embryonic kidney
(HEK293T) cells and NIH3T3 ﬁbroblasts to 10Gy IR and
SPL protein levels were examined by immunoblotting. As
shown in Figure 1a, SPL protein levels were elevated in
response to IR in both cell lines. SPL induction in response to
IR was even more pronounced at higher dose
(Supplementary Figure 1). In contrast to SPL protein levels,
SPL message levels were not consistently altered under
these conditions (data not shown), which suggests that SPL
protein accumulates in response to IR through a translational
or posttranslational mechanism. To investigate the
ramiﬁcations of SPL upregulation on irradiated cells,
HEK293T cells exhibiting constitutively high SPL activity by
virtue of stable overexpression of human SPL (SPL
hi cells)
and HEK293T vector control cells containing low
endogenous SPL levels
17 were irradiated, and apoptosis
was evaluated. As shown in Figure 1b, SPL
hi cells exhibited
enhanced sensitivity to IR as shown by an increase in
apoptosis measured by caspase-3 activity and by the
presence of PARP cleavage products (Figure 1c) and sub-
G1 peak (Figure 1d). To determine the role of SPL in
apoptotic signaling pathways, cytochrome c release into the
cytosol was examined by immunoblotting. In response to IR,
SPL
hi cells and control cells both released cytochrome c into
the cytoplasm (Supplementary Figure 2). However, SPL
hi
cells showed greater cytochrome c release into the cytosol
compared with control cells. Further, treatment with inhibitors
of caspases, including those involved in extrinsic (caspase-8)
Figure1 SPLisaradioresponsiveproteinthatincreasesradiation-inducedcelldeath.(a)HEK293TandNIH3T3cellswereleftuntreatedorirradiatedwith10GyofX-rays.
Cells were harvested 9h (HEK293T) or 24h (NIH3T3) after radiation exposure and whole cell lysate was immunoblotted with actin and anti-human SPL, or anti-murine SPL
antibodies,respectively.(b andc)ControlandSPL
hicellswereexposedwith indicateddoseof IR.After 24h ofincubation,cellswereharvested,andapoptosiswasassessed
by measuring caspase-3 activity (b) and cell lysate was immunoblotted for PARP (Poly (ADP-ribose) polymerase). (c) Caspase-3 activity experiment represents mean±S.D.
of three independentexperiments.The immunoblot is representativeof at leastthree independentexperiments.(d) Control and SPL
hi cells wereleft untreatedor subjectedto
5Gy dose of X-rays and cells were harvested 12, 24 and 36h after radiation exposure. Apoptosis was determined by ﬂow cytometry using propidium iodide staining. Values
are shown as mean±S.D. of three independent experiments. (e)C o n t r o l ,S P L
hi, and SPL
hi cells expressing a shRNA speciﬁc for Sgpl1 (SPL
hi/shRNA) were exposed to 10Gy IR.
After 24h of incubation, caspase-3 activity was measured in whole cell lysate. Sgpl1 knockdown was conﬁrmed by western blotting (inset). Data represents mean±S.D. of
threedifferentexperimentsdoneinduplicates.(f)EndogenousknockdownofSgpl1inducesradio-resistance.HEK293Tcontrolcellswithlentiviralvector(control,openbar)or
with shRNA speciﬁc for sgpl1 (SPL
lo; solid bar) were exposed to 10Gy X-rays and caspase-3 activity was measured 36h after radiation exposure. Sgpl1 knockdown was
conﬁrmed by RT-PCR (inset). Data are shown as mean±S.D. (n¼3, *Po0.01). Each experiment was repeated at least three times. Data points indicate average±S.D. of
representative experiment
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Cell Death and Diseaseand intrinsic (caspase-9) apoptotic pathways, attenuated
radiation-induced apoptosis in SPL
hi cells, as shown in
Supplementary Figure 3. To conﬁrm that the IR-sensitive
phenotype of SPL
hi cells is speciﬁcally attributed to SPL
overexpression and not an acquired genetic modiﬁcation
associated with stable transformation, SPL overexpression
was reversed by lentiviral expression of a shRNA molecule
that speciﬁcally targeted human SPL. As shown in Figure 1e,
SPL knockdown reversed the radiosensitive phenotype of
SPL
hi cells. Further, knockdown of endogenous SPL in
HEK293T cells (SPL
lo cells) conferred an IR-resistant
phenotype, demonstrating a role for endogenous SPL in
radiation-induced apoptosis (Figure 1f). Together, these
ﬁndings reveal SPL to be a radiation-responsive protein
that sensitizes cells to IR through an apoptotic pathway or
pathways involving mitochondrial permeability transition and
activation of caspases.
SPL promotes premature release from cell cycle arrest
after IR. Cell cycle arrest is a critical component of the DDR
that allows cells sufﬁcient time to repair damaged DNA
molecules before entry into mitosis, thereby insuring
genomic integrity. We examined the effect of SPL on cell
cycle arrest after IR using propidium iodide staining coupled
with ﬂow cytometry. Both control and SPL
hi cells exhibited a
normal cell cycle distribution at baseline, and both arrested
appropriately in G2, as shown by a large peak of cells
containing 4N DNA content 12h after treatment with 10Gy
IR (Figure 2a). These ﬁndings suggest that SPL does not
interfere with the initiation of G2 cell cycle arrest in response
to DNA damage. However, whereas control cells maintained
the G2 arrest for 24h, as shown by a single population of
cells containing 4N DNA content, analysis of SPL
hi cells 24h
after IR revealed two peaks, one representing cells with 4N
DNA content and one representing cells with 2N DNA
content. These ﬁndings indicate that a population of SPL
hi
cells had entered G1 phase at this time point. The 4N peak in
the cell cycle histogram does not distinguish between cells in
G2 versus M phase. Therefore, to identify cells in mitosis, we
performed immunoblotting for the mitotic marker Ser10-
phosphohistone-H3 (S10-H3) in comparison with total
histone-H3. As shown in Figure 2b, control irradiated cells
contained reduced levels of S10-H3 compared with
untreated cells 12h through 24h after IR, consistent with
induction and maintenance of G2 cell cycle arrest in
response to DNA damage. SPL
hi cells treated with IR also
demonstrated reduced S10-H3 levels 12h after IR. However,
by 18 and 24h the S10-H3 levels in SPL
hi cells had
recovered, indicating the presence of a signiﬁcant
population of cells in mitosis. In contrast, there was no
appreciable difference in total histone-H3 levels in the two
cell lines. Mitotic index was quantiﬁed by immunocytometry
as well as by immunoﬂuorescent staining using a S10-H3
antibody (Figure 2c and Supplementary Figure 4). SPL
hi cells
exhibited a high mitotic index at baseline as well as after IR in
comparison with control cells, whereas irradiated SPL
lo cells
exhibited a lower mitotic index than irradiated control cells.
Importantly, knockdown of SPL restored the ability of SPL
hi
cells to maintain G2 arrest after IR (Figure 2d). Together,
these ﬁndings demonstrate that SPL does not interfere with
initiation of G2 arrest but prevents the maintenance of G2
arrest, leading to premature entry into mitosis after genotoxic
injury.
SPL expression affects the Cdk1–cyclin B complex. The
G2 to M transition is controlled by the Cdk1–cyclin B
complex, and premature activation of this complex can lead
to inappropriate cell cycle progression and radiation-induced
mitotic catastrophe.
20 Therefore, we examined the inﬂuence
of SPL expression on both components of this kinase
complex. Compared with control cells, SPL
hi cells
demonstrated higher CDK1 and cyclin B1 protein
expression beginning 12h and continuing through 24h after
IR (Figure 2b). Mitotic progression in the face of persistent
DNA damage could lead to apoptosis of SPL
hi cells.
Consistent with this notion, pretreatment of SPL
hi cells with
cell cycle inhibitors (Supplementary Figure 5) and a Cdk1
inhibitor prevented inappropriate cell cycle progression and
reversed the IR-sensitivity of SPL
hi cells, as shown in
Figure 2e and Supplementary Figure 6. Thus, we conclude
that SPL radiosensitizes cells by abbreviating G2 cell cycle
arrest through a Cdk1–cyclin B-dependent mechanism that
promotes cell cycle progression and potentiates apoptosis
after IR exposure.
SPL sensitizes cells to IR by depleting cellular S1P and
elevating ceramide levels. SPL catalyzes the conversion
of S1P into hexadecanal and ethanolamine phosphate in the
ﬁnal step of the sphingolipid degradation biochemical
pathway. SPL could mediate its radiosensitizing effects by
lowering intracellular S1P, by increasing the products of S1P
breakdown, or through some indirect effect. As shown in
Figure 3a, SPL
hi cells contain low S1P levels. However,
addition of S1P did not rescue the IR-induced cell death in
SPL
hi cells (data not shown). To avoid issues related to
ineffective delivery of exogenous S1P to cells, we employed
a genetic strategy to increase intracellular S1P through
overexpression of sphingosine kinase 1 (SK1). As shown in
Figures 3b and c, the IR-sensitivity of SPL
hi cells was
partially reversed by SK1 overexpression. These ﬁndings
indicate that S1P depletion is partially but not completely
responsible for the effect of SPL on radiation responses.
Radiation-induced ceramide generation contributes to
cellular apoptosis and acute radiation syndromes.
7
Therefore, we also measured intracellular ceramide content
at baseline and after IR of control and SPL
hi cells via mass
spectrometry (Table 1). As expected, both cell lines showed
an increase in ceramide levels after IR. Surprisingly,
however, SPL
hi cells contained 50% greater ceramide
content compared with control cells under baseline
conditions as well as after IR. Immunoﬂuorescent staining
of permeabilized cells using a ceramide-speciﬁc antibody
further conﬁrmed the high ceramide levels in SPL
hi cells
compared with control cells (Figures 3d and e). These
ﬁndings conﬁrm that SPL expression leads to an increase in
ceramide levels. Ceramide can be generated by de novo
biosynthesis or hydrolysis of membrane sphingomyelin.
To explore whether SPL radiosensitizes cells in a
ceramide-dependent fashion, apoptosis was quantitated in
irradiated control and SPL
hi cells that had been treated
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Cell Death and Diseasebefore IR with either desipramine, which causes proteolysis
of the ASMase protein and thereby blocks ceramide
formation from SM, or inhibitors of de novo ceramide
biosynthesis including myriocin (which inhibits serine
palmitoyltransferase) or fumonisin B1 (which inhibits
ceramide synthase). As shown in Figure 4a, only
desipramine pretreatment blocked apoptotic responses to
IR in SPL
hi cells, indicating that SPL promotes IR-induced
apoptosis through a process involving ASMase-dependent
generation of ceramide from SM.
SPL regulates the DNA damage response
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ASMase. Neutral, acidic and alkaline SMase enzymes are
responsible for metabolizing membrane and dietary SM to
form ceramide. However, the localized expression pattern of
alkaline SMase makes it an unlikely source of ceramide in
our model system. Therefore, we examined the effect of SPL
expression on both acidic and neutral SMase activities
before and after IR. As shown in Figure 4b, ASMase
activity was 50% higher in SPL
hi cells than in control cells.
As expected, ASMase activity was reduced to negligible
levels in SPL
hi cells treated with desipramine. In contrast,
neutral SMase activity was unaffected by SPL expression
(Figure 4c). To determine the etiology of elevated ASMase
activity in SPL
hi cells, we evaluated ASMase protein
expression by immunoblotting. As shown in Figure 4d,
ASMase protein levels were higher in SPL
hi cells compared
with control cells. To conﬁrm this ﬁnding, confocal
microscopy was performed on ﬁxed, nonpermeabilized
control and SPL
hi cells stained with an ASMase-speciﬁc
antibody. As shown in Figures 4e and f, SPL
hi cells exhibited
Figure2 SPLpromotesearlyreleasefromcellcyclearrestandinappropriateentryintomitosis.(a)ControlandSPL
hicellswereirradiatedwith10GyX-raysandharvested
at indicated time points. Cell cycle distribution was examined by ﬂow cytometry using PI staining. The percentage of cells in each stage of the cell cycle at 0, 12, 24 and 36h
afterirradiation is shown withineach histogram. (b) Control and SPL
hi cells were left untreated or irradiated and harvested at the indicatedtime points, and whole cell extracts
were immunoblotted with phospho-histone H3 (Ser10), total histone H3, CDK1, cyclin B1 and actin antibodies. Immunoblots are representative of at least three independent
experiments. (c) SPL
hi cells exhibits increased mitosis after DNA damage. Control (open bar), SPL
hi (solid bar), and SPL
lo (hatched bar) cells were left untreated or irradiated
and cells were harvested 16h after radiation exposure. Mitotic index was determined by phospho-histone H3 (Ser 10) staining followed by ﬂow cytometry. Data are shown as
mean±S.D.(n¼3,**Po0.01forbaselinecontrolversusSPL
hi;*Po0.05forirradiatedcontrolversusSPL
hi).(d)Control,SPL
hiandSPL
hi/shRNAcellswereleftuntreatedor
irradiatedandcellswereharvested36hafterradiationexposure.CellcycledistributionwasanalyzedbyﬂowcytometryusingPIstaining.Thepercentageofcellsineachstage
of the cell cycle is presented for each cell line in comparative bar graph format. Histogram is representative of three different experiments. (e) Blockage of mitotic progression
abrogates SPL-mediated apoptosis. Control and SPL
hi cells were left untreated or pretreated with a CDK1 inhibitor (Nu6102, 10mM) for 1h. Then, cells were irradiated and
caspase-3 activity measured 24h after radiation exposure. Data are shown as mean±S.D. (n¼3, **Po0.001 for SPL
hi irradiated versus SPL
hi irradiated with CDK1
inhibitor)
Figure 3 SPL sensitizes cells to apoptosis after DNA damage by depleting S1P and increasing ceramide levels. (a) Total cellular S1P content in control (open bar) and
SPL
hi (solid bar) cells was quantitated by LC–MS and normalized to total phospholipids of whole cell extracts. Data are shown as mean±S.D. of three different experiments.
*Po0.01. (b) Sphk1 (SK1) was overexpressed in SPL
hi cells using a pBabe mammalian expression system. SPL
hi cells with empty vector (SPL
hi-pBabe) or SPL
hi cells with
forced SK1 expression (SPL
hi-SK1) were left untreated or subjected to IR, and 36h later apoptosis was assessed by measuring caspase-3 activity. Data are shown as
mean±S.D.(n¼3). (c)Whole celllysatesfrom SPL
hicells with empty vector(SPL
hi-pBabe)orSPL
hicells with forcedSK1 expression(SPL
hi-SK1) wereimmunoblottedwith
SK1 or actin antibodies. (d) Control and SPL
hi cells were grown on poly-L-lysine coated culture slides for 24h. Immunolabeling was performed for ceramide in ﬁxed and
permeabilizedcells.Imageswereacquiredusingalaser-scanningmicroscope(LSM710).(e)FluorescenceintensityforceramidewasquantitatedusingNIHImageJsoftware.
Data are shown as mean±S.E.M. (n¼2, *Po0.01)
SPL regulates the DNA damage response
A Kumar et al
5
Cell Death and DiseaseTable 1 Ceramide levels in control and SPL
hi cells
Ceramide molecular species
Sample C16 C18 C20 C22 C24 C16-DH C24-DH Total ceramide
Control untreated 6.26±0.76 1.63±0.05 0.25±0.05 1.47±0.14 6.54±0.61 0.24±0.06 0.35±0.04 16.74±1.56
SPL
hi untreated 8.17±0.41 2.77±0.21 0.35±0.04 2.66±0.15 9.77±0.51 0.27±0.01 0.48±0.06 24.68±0.84
SPL
hi+siRNA untreated 6.97±0.28 2.05±0.12 0.29±0.11 2.0±0.11 7.89±0.90 0.24±0.05 0.40±0.05 19.85±1.24
Control+IR 8.06±1.57 1.94±0.35 0.28±0.08 1.72±0.35 7.24±1.07 0.26±0.02 0.45±0.09 19.94±3.47
SPL
hi+IR 12.42±0.81 3.54±0.20 0.53±0.10 3.43±0.10 12.68±0.86 0.39±0.03 0.64±0.13 33.62±2.27
SPL
hi +siRNA+IR 9.21±0.52 2.55±0.19 0.32±0.02 2.39±0.06 9.35±0.51 0.24±0.02 0.33±0.06 24.38±2.27
Abbreviation: DH, dihydroceramide. Control or SPL
hi cells were grown in six-well plate for 24h. Then, the control or SPL
hi cells were either mock transfected or
transfected with acid sphingomyelinase siRNA for 48h, then cells were left untreated or irradiated and harvested 24h after radiation exposure (IR). Cellular ceramide
was quantitated by LC–MS and are presented as nmoles/mg of phosphatidylcholine. Values are shown as mean±S.D.
Figure 4 ASMase is activated in the presence of SPL. (a) Inhibition of ASMase by desipramine protects against radiosensitivity of SPL
hi cells, whereas inhibitors of
the de novo pathway do not. Control and SPL
hi cells were left untreated or pretreated with fumonisin B1 (25mM), myriocin (10mM) or desipramine (20mM) for 3h
then cells were irradiated. Caspase-3 activity was measured 24h after radiation exposure. (b and c) ASMase activity is upregulated in SPL
hi cells, which was blunted by
desipramine. Control and SPL
hi cells (1 10
6) were grown in six-well plate for 24h. SPL
hi cells were either left untreated or treated with desipramine (20mM) for 6h. Cells
were harvested and then acid (b) and neutral SMase (c) activity was assayed. Data are shown as mean±S.D. (n¼4, *Po0.001 (b)). (d) Immunoblotting for ASMase in
controlandSPL
hicells(leftpanel).RelativeintensityofASMaseexpressionwasquantiﬁedbydensitometry(rightpanel).(e)SPLupregulatesmembraneassociated-ASMase.
Control and SPL
hi cells were grown on poly-L-lysine coated culture slides for 24h. Immunolabeling was performed for ASMase in ﬁxed, non-permeabilized cells. Images were
acquiredusingalaserscanningmicroscope(LSM710).(f)FluorescenceintensityforASMasewasquantitatedusingNIHImageJsoftware.Dataareshownasmean±S.E.M.
(n¼2, *Po0.01)
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Cell Death and Diseasehigh levels of membrane-associated ASMase compared with
control cells. As shown in Supplementary Figure 7, ASMase
message levels were not different in the two cell lines,
suggesting a translational or posttranslational effect.
Inhibition of ASMase or p38 reverses the radiosensitive
phenotype of SPL
hi cells. To conﬁrm the role of ASMase in
mediating the effect of SPL on radiation responses, cells
were pretreated before IR with monensin, an antibiotic that
reduces ASMase activity by inhibiting lysosomal acidiﬁcation.
Caspase-3 activity was subsequently determined in whole
cell extracts as a measure of IR-induced apoptosis. Figure 5a
shows that chemical inhibition of ASMase attenuates the
IR-sensitive phenotype of SPL
hi cells. Inhibition of ASMase
also abrogated the accumulation of different ceramide
molecular species in SPL
hi after radiation exposure (data
not shown). In addition to chemical inhibition of ASMase,
siRNA was used to knock down ASMase expression,
resulting in a 66% inhibition of enzyme activity, as shown in
Figure 5b (inset). Speciﬁc knockdown of ASMase partially
reversed the sensitization of SPL
hi cells to IR (Figure 5b) and
also led to a reduction in ceramide levels in SPL
hi cells, as
shown in Table 1.
To determine whether ASMase contributes to the attenua-
tionofG2arrestafterIRinSPL
hicells,wepretreatedcellswith
either desipramine or monensin, followed by IR of cells and
analysis of cell cycle distribution of living cells 24h after IR. As
shown in Figures 5c and d, SPL
hi cells behaved similarly to
control cells and maintained G2 cell cycle arrest after IR when
ASMase was inhibited. Our ﬁndings indicate that both S1P
depletion and ceramide generation through the actions of
ASMase contribute to the radiosensitive phenotype of SPL
hi
cells. Further, the effect of SPL on maintenance of the G2
arrest and resulting increase in apoptosis after radiation
requires the expression and activity of ASMase.
The p38 MAPK is required for SPL’s ability to promote
apoptosis in response to chemotherapy agents
16,21 and is
activated by IR and ceramide.
22,23 To assess the role of p38
MAPK in SPL-mediated radiosensitization, control and SPL
hi
cells were pretreated with the p38 inhibitor SB203580,
followed by IR. As shown in Supplementary Figure 8,
inhibition of p38 completely prevented apoptosis in response
to IR in SPL
hi cells, demonstrating that SPL sensitizes cells to
IR through a p38-dependent process.
SPL delays the kinetics of DNA repair. The normal
cellular response to DNA damage involves both cell cycle
arrest and activation of DNA repair mechanisms. To explore
the effects of SPL on DNA repair, we investigated the extent
of DNA damage and kinetics of DNA repair after IR in control
Figure 5 ASMase is responsible for the effects of SPL on the DDR. (a) Control and SPL
hi cells were left untreated or pretreated with Monensin (50nM) for 3h then cells
wereexposedtoIR andcaspase-3activity wasmeasured24hafterradiation exposure. (b)SPL
hicellswereeithermocktransfectedortransfectedwith siRNAagainst human
ASMasegene(SMPD1).After48h,cellswereirradiatedandharvestedafter24h.ASMaseactivityinknockdownandmocktransfectedcellswas assayed.Caspase-3activity
was measured using DEVD-pNA as a substrate. Data represent mean±S.D. of three independent experiments. (*Po0.01; **Po0.001). (c and d) Control and SPL
hi cells
were pretreated with 20mM desipramine or 250nM monensin for 3h. Cells were then exposed to IR and harvested 24h after irradiation, and cell cycle distribution was
examined by ﬂow cytometry using PI staining. Histograms are representatives of three different experiments
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Comet assay. In Figure 6a, Comet assays show that control
and SPL
hi cells contain mostly intact DNA under baseline
conditions. One minute after IR, control and SPL
hi cells
demonstrate evidence of damaged DNA, illustrated by the
comet tail. By 30min, most of the DNA damage has been
repaired in control cells, as shown by the lack of comet tails.
In contrast, SPL
hi cells continue to exhibit evidence of DNA
damage 30min after IR. These results are depicted
quantitatively using the olive tail moment measurement, as
shown in Figure 6b. Conversely, SPL
lo cells exhibited a
greater degree of DNA repair compared with control cells, as
shown in Figure 6c and quantitatively in Figure 6d.
These ﬁndings indicate that endogenous SPL has a
negative inﬂuence on the kinetics and/or efﬁciency of DNA
repair, whereas reducing SPL expression hastens DNA
repair after IR.
Inhibition of SPL affords radioprotection in vivo. On the
basis of our ﬁndings in HEK293T cells, we hypothesized that
SPL may function as a target for radioprotection in vivo.
To examine this possibility, tetrahydroxybutylimidazole (THI),
a food additive that serves as a small molecule inhibitor of
SPL, was delivered (25mg/l) to mice in the drinking water.
24
Following 24-h treatment with either THI or vehicle, mice
were subjected to 14Gy total body IR (TBI) and monitored for
survival. As shown in Figure 7a, tissue SPL activity was
signiﬁcantly reduced and plasma S1P levels were elevated
signiﬁcantly in mice receiving THI (Figure 7b). Importantly,
SPL inhibition afforded radioprotection in vivo as shown by
an increase in survival time (Figure 7c) of mice exposed to a
lethal dose of TBI. These ﬁndings suggest that SPL may
serve as a target for radioprotection in vivo.
Discussion
In this study, we found that SPL is activated by IR and
functions as a modulator of the DDR. Speciﬁcally, we found
that IR-induced G2 cell cycle arrest is initiated properly but is
not maintained in cells expressing high levels of SPL, thereby
leading to premature entry into mitosis. SPL expression also
sensitized cells to IR-induced apoptosis, a characteristic that
could be reversed by pretreatment with chemical inhibitors of
G2 cell cycle progression. In contrast, SPL-deﬁcient cells
were resistant to IR-induced apoptosis. These ﬁndings
suggest that SPL mediates IR-induced apoptotic cell death
through a process that requires mitotic progression. Whether
this process involves a form of mitotic death or whether
apoptosis is induced later in the progression of the cell
cycle will require further study.
20 Although previous reports
have provided evidence that sphingolipid metabolites can
inﬂuence cell cycle progression, to our knowledge this is the
ﬁrst report linking S1P and SPL to the regulation of cell cycle
progression.
The effect of SPL on G2 maintenance was associated with
premature activation of the Cdk1–cyclin B complex. G2 arrest
involves multiple discrete steps including initiation, mainte-
nance, adaptation and release that occur through distinct
mechanisms. For example, maintenance of the G2 arrest
depends on reduced levels of the Cdk1–cyclin B complex and
p53,whereasinitiationofG2arrestdoesnotdependonp53.
25
Figure 6 SPL delays the kinetics of DNA repair. (a) Control and SPL
hi cells were left untreated or irradiated and harvested 1 or 30min after radiation exposure. Extent of
DNA damage was analyzedby comet assayusing alkalineelectrophoresis. In each sample,50 cells werescored. (b) Olive tail momentfor control (open bar) and SPL
hi (solid
bar) cellswas analyzedusingKomet6.0software.(c)Control andSPL
lo cellswereleft untreatedor irradiated andharvested30min afterradiationexposureandcomet assay
was done using neutral electrophoresis. (d) Olive tail moment for control (open bar) andSPL
lo (solid bar) was analyzed.Photomicrographs and histogramsare representative
of three independent experiments. (b and d) data represents mean ±S.D. of three independent experiments (*Po0.01)
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complex remains to be determined.
26 Cells respond to DNA
damage by activating a complex network of signal transduc-
tion pathways. Mutations in different components of the DDR
pathways(e.g.,ataxiatelengiectasiamutated(ATM),BRCA1/2,
NBS1 and Mre11) lead to cell cycle checkpoint defects,
decreased ability to repair damaged DNA, and an increased
sensitivity to IR and other DNA damaging agents.
27 Interest-
ingly, SPL
hi cells exhibited reduced ATM and checkpoint
kinase 1 (Chk1) protein levels compared with control cells,
while SPL
lo cells exhibited increased ATM and Chk1 levels
(datanotshown).However,overexpressionofATMorChk1in
SPL
hi cells did not attenuate apoptosis in response to IR.
These ﬁndings suggest that deﬁciency of ATM and/or Chk1
are not the primary or at least not the major factors underlying
the ability of SPL to inﬂuence the DDR.
SPL expression reduces cellular levels of the bioactive
sphingolipid, S1P. We found that S1P depletion by SPL
sensitizes cells to radiation, consistent with previous reports
indicating that S1P acts as a radioprotectant in ovaries, gut
and endothelium.
14,28 However, the radiosensitive phenotype
of SPL
hi cells could not be fully reversed using strategies to
restore cellular S1P levels. This led to the discovery that cells
expressing SPL accumulate ceramide through an ASMase-
dependent mechanism. Further, ASMase expression, activity
and ASMase-dependent ceramide accumulation were
required for the ability of SPL to abbreviate cell cycle arrest
and promote apoptosis of irradiated cells. These ﬁndings are
consistent with the important role of ASMase in radiation
responsiveness and reveal an unexpected positive feedback
loop linking ceramide catabolism to ceramide recycling from
membrane sphingomyelin. It is likely that by raising ceramide
levels, SPL lowers the threshold required to activate
apoptosis in response to DNA damage. Inhibition of p38 also
blocked apoptosisin SPL
hi cellsafter IR,consistent with a role
for this stress-activated kinase in the pro-apoptotic actions of
both ceramide and SPL.
Cellular ASMase activity is regulated at transcriptional and
posttranslational levels.
29 Additional mechanisms of regula-
tion involve the trafﬁcking of ASMase to the lysosome, the
outer leaﬂet of the plasma membrane, and its secretion into
the extracellular space. In particular, recent studies suggest
that membrane-translocated ASMase generates the cera-
mide pool that promotes apoptosis after exposure to IR.
30 Our
ﬁnding of increased total cellular ASMase protein levels and
increased membrane-associated ASMase in SPL
hi cells may
point to a potential role for SPL in these processes.
Finally, we demonstrate that downregulation of SPL leads
to increased DNA repair kinetics in vitro. Importantly, we also
show that administration of the nontoxic food additive THI to
mice reduces SPL activity, raises plasma S1P levels and
signiﬁcantlyprolongsanimalsurvivalafteralethaldoseofTBI.
SPL null mice exhibit developmental defects, lymphocyte
trafﬁcking defects and death within 1–2 months after birth.
Whereas chronic and complete inhibition of SPL may there-
fore not be advisable, partial inhibition of SPL using THI and
other chemical inhibitors of SPL is a strategy that has been
recently exploited for immunomodulatory purposes and
appears to be well tolerated.
24,31 Thus, we propose that
SPL inhibition using these or similar agents may be a useful
strategy for achieving radioprotection in acute situations such
as the delivery of therapeutic radiation in cancer patients or to
mitigate injury after accidental radiation exposure.
Materials and Methods
Materials. Dimethyl sulfoxide, BSA, desipramine, paraformaldehyde, propidium
iodide, RNaseA, polybrene, puromycin and crystal violet were from Sigma
(St. Louis, MO, USA); S1P was from Matreya, LLC (Pleasant Gap, PA, USA).
Fumonisin B1 and myriocin were from Cayman (Ann Arbor, MI, USA). NBD-S1P
was from Avanti Polar Lipids (Alabaster, AL, USA). Monensin and Nu6102 were
from Enzo Life Science (Plymouth Meeting, PA, USA). THI was from Albany
Molecular Research Inc. (Albany, NY, USA). [Choline-methyl-
14C]SM is from
American Radiolabeled Chemicals (St. Louis, MO, USA).
Cell culture and irradiation. Stable clones of human SPL–GFP fusion
protein or pcDNA 3.0 vector were generated in human embryonic kidney
(HEK293T) as described.
17 Cells were propagated in Dulbecco’s modiﬁed Eagle’s
medium with high glucose (Cell culture facility, UCSF, San Francisco, CA, USA)
containing 10% fetal bovine serum (JR Scientiﬁc, Woodland, CA, USA), penicillin
(100 units/ml) and streptomycin (100mg/ml), at 371C with 5% CO2. Cells were
irradiated at room temperature with an X-ray generator, RS-2000 Biological
Irradiator (Rad Source Technologies, Inc., Alpharetta, GA, USA) operating at
160kV and 25mA, yielding an absorbed dose rate of 2.2Gy/min. Unless otherwise
stated, cells were irradiated with 10Gy dose of IR.
Figure 7 Inhibition of SPL prolongs survival in mice after a lethal dose of
radiation. Mice were given THI (25mg/l) or vehicle control in the drinking water for
24h. Following vehicle (control) or THI (THI) treatment, mice were euthanized.
(a) SPL activity was measured in intestine, and (b) plasma S1P levels were
quantitated. Values represent the mean±S.D. from 3–5 mice in each group.
(c) Following vehicle (control, n¼14) or THI (THI, n¼16) treatment, mice were
subjected to 14Gy TBI and survival of mice was recorded daily
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Cell Death and DiseaseGeneration of SK1 overexpressing cells. Plasmid eGFP-SK1-Flag
(generous gift of Stuart Pitson
32) was ﬁrst digested with HindIII and treated with
Klenow fragment of E. coli DNA polymerase to ﬁll in the 50-overhang and was then
cut with EcoRI to release the GFP–SK1 fragment. Following gel puriﬁcation, this
fragment was ligated to a sequentially digested pBabe-Puro, ﬁrst with BamHI and
blunted as above, and then with EcoRI. Transfection of the resultant plasmid into
HEK293T–SPL
hi cells was performed via the Ca2PO4 precipitation method and
stable clones were established by selection on 2mg/ml puromycin for 3 weeks.
33
ASMase siRNA. Cells were plated in six-well plates in DMEM H-21 containing
10% FBS without antibiotics. After 24h, 100nM ASMase (SMPD1) siRNA
(Dharmacon, Lafayette, CO, USA) were transfected with Lipofectamine 2000.
Control cells were similarly treated with non-targeting siRNA control. At 48h after
transfection, the cells were exposed to IR.
SPL knockdown. The lentiviral vector pLKO.1 (Addgene plasmid 10878) was
used to clone shRNAs targeting the human SPL gene Sgpl1 according to pLKO.1
protocol (http://www.addgene.com). The virions were produced by transfection of
HEK293T cells using the recombinant pLKO.1 along with packaging plasmid
psPAX2 (Addgene plasmid 12260) and the envelope-encoding plasmid pMD2.G
(Addgeneplasmid12259).At 48h post-transfection,thespentmediacontainingthe
lentiviral particles was collected. This was used to infect control and SPL
hi cells in
the presence of 8mg/ml polybrene. Stable clones were selected with puromycin
(1.5mg/ml).Thesurvivingcolonieswerescreenedfor humanSPLexpressionlevels
using RT-PCR or western blotting.
Caspase 3 activity. Caspase-3 substrate Ac-DEVD-pNA was from Enzo Life
Sciences. Caspase-3 assays were performed as described.
17
RT-PCR. Total RNA was isolated from cells using Trizol reagent (Invitrogen,
Carlsbad, CA, USA) according to the manufacturer’s instructions. Primers for
human Sgpl1 and actin were: Sgpl1 forward 50-GATAGAGGCAGAAATTGTGAGG
ATA-30, Sgpl1 reverse 50-GTATTTTGTATTTGACAGCCAGCTT-30, actin forward
50-AGAAAATCTGGCACCACACC-30 and actin reverse 50-AGAGGCGTACAGGGA
TAGCA-30. RT-PCR was performed using the one-step RT-PCR kit (Qiagen,
Valencia, CA, USA).
Immunoblotting. Immunoblotting was performed as described.
16 Antibodies
to PARP, cyclin B1, CDK1, ASMase and HRP-conjugated anti-rabbit and anti-
mouse antibodies were from Cell Signaling Technologies (Beverly, MA, USA).
Antibody to actin was from Sigma. Antibody to phospho-histone H3 (Ser10) was
from Millipore (Billerica, MA, USA). Histone H3 antibody was from Genscript Inc.
(Piscataway, NJ, USA). Antibodies against SPL were described previously.
16 SK1
antibody was from Abcam (Cambridge, MA, USA). Relative intensities of auto-
radiogram bands were quantitated using NIH ImageJ (http://rsbweb.nih.gov/ij/).
Comet assay. Control, SPL
hi or SPL
lo cells 0.5 10
6 were plated in six-well
platesandpropagatedfor24h.Cellsweremock-treatedorgiven10Gyofradiation.
Cells were rested at 371C for the indicated times, and alkaline or neutal comet
assay was performed using the Comet Assay kit (Trevigen, Gaithersburg, MD,
USA). Comet images stained with 1mg/ml SYBRGreen (Trevigen) were captured
using an inverted ﬂuorescent microscope (Axiovert 200, Carl Zeiss, Thornwood,
NY, USA). Olive tail moment was analyzed using Komet 5.0 software (Andor
Technology, South Windsor, CT, USA).
Cell cycle analysis. Cells (1 10
6) were collected by trypsinization and
washed with PBS. Cells were ﬁxed in chilled 70% ethanol for 1h on ice. After
washing with PBS, cells were stained with a solution containing 40mg/ml propidium
iodide and 100mg/ml of RNase A. Cells were evaluated for DNA content using a
FACSCalibur (Becton Dickinson, San Jose, CA, USA) ﬂow cytometer. Data were
analyzedbyCellQuestProsoftware(BectonDickinson).Deadcellsandaggregates
were excluded from analysis by gating cells in a FL2-A versus FL2-W scatter plot.
Immunocytometry. Cells (1 10
6) were collected by trypsinization and after
washingwere ﬁxed in ice-cold70% ethanolfor up to 24h at  201C. After washing,
cells were permeabilized with 0.25% Triton-X 100 in PBS for 15min on ice. After
blocking,cellswerestainedwithantibodyagainstS10H3Ser10(Millipore)for1hat
room temperature, followed by incubation with Alexa Fluor 555 conjugated goat
anti-rabbit antibody (Invitrogen). Cellular ﬂuorescence was monitored with a
FACSCalibur (Becton Dickinson) ﬂow cytometer. Data were analyzed by CellQuest
Pro software.
Detection of ceramide and ASMase surface expression by
confocal microscopy. Control and SPL
hi cells were grown for 24h on
poly-L-lysine coated eight-well chamber slides (BD Biosciences, San Jose, CA,
USA).Todetectceramide,cellswerewashedincoldPBSandﬁxedfor15minin4%
paraformaldehyde. After washing, cells were permeabilized with 0.3% Triton-X-100
in PBS for 10min at room temperature. Cells wereblocked with 5% goat serumand
0.1% Triton-X-100 in PBS for 1h at room temperature. Cells were stained with
primaryantibodytoceramide(AlexisCorporation,Lausen,Switzerland)overnightat
41C, washed three times in PBS, and stained with Cy3-conjugated secondary
antibody (Jackson Immunoresearch Laboratories, Inc., West Grove, PA, USA) for
1h at room temperature. To detect surface expression of ASMase, cells were
processedasdescribedabove,exceptthatcellswerenotpermeabilized,andTriton-
X-100wasexcludedfromblockingandantibodyincubationbuffer.Todetectsurface
expression of ASMase, cells were stained with primary antibody to ASMase (Santa
CruzBiotechnology,SantaCruz,CA,USA)overnightat41C,washedthreetimesin
PBS, and stained with Cy3-conjugated secondary antibody (Jackson
Immunoresearch Laboratories, Inc.) for 1h at room temperature. Nonspeciﬁc
ﬂuorescence was excluded by performing a control without primary antibody. Cells
were washed three times, stained with DAPI and mounted in mounting medium.
Images were captured using a laser scanning microscope and software (LSM 710,
Carl Zeiss, Inc.). Images were processed using Adobe Photoshop (Adobe,
San Jose, CA, USA). Fluorescence intensity was quantitated using NIH ImageJ
software.
SMase assay. SMase assay was performed using [choline-methyl-
14C]SM
substrate as described.
28
Sphingolipid quantitation. S1P and total ceramide were quantitated as
described.
17,34
Mice irradiation and survival of mice. C57BL/6 female mice (8–12
weeks old) were from Charles River Laboratory (Wilmington, MA, USA). TBI was
delivered with a
137Cs irradiator (Shepherd Mark-I, JL Shepherd & Associates, San
Fernando, CA, USA) at a dose rate of 2.41Gy/min.
35 Before TBI, mice were given
vehicle control or THI (25mg/l) in the drinking water for 24h. Actuarial survival was
calculated by the product-limit Kaplan–Meier method, and P-values were evaluated
by the Mantel log-rank test.
35
SPL assay. SPL activity was measured in mouse intestine using a ﬂuorescent
NBD-S1P substrate.
36
Statistical analysis. Comparison between two groups was carried out by
unpaired Student’s t-test. Survival curve was plotted by the product-limit
Kaplan–Meier method, and P-values were evaluated by the Mantel log-rank test
using SPSS software (Chicago, IL, USA).
Conﬂict of interest
The authors declare no conﬂict of interest.
Acknowledgements. This work was supported by National Institutes of
Health Grants CA77528 and AI078516 (JDS), RC1 ARRA supplemental grant and
generoussupportfromtheSwimAcrossAmericaFoundation(BO).WethankDamir
Sudar (Lawrence Berkeley National Laboratories) for assistance with confocal
microscopy,andJohnMurnaneandGloriaReynolds(UniversityofCaliforniaatSan
Francisco) and Eleanor Blakely and Kathy Bjornstad (Lawrence Berkeley National
Laboratories) for assistance with mouse irradiation.
Author contributions
AK designed and performed the experiments, analyzed data and helped write the
paper. BO generated molecular constructs used throughout the study and
performed experiments and analyzed data. HF, FP and MZ performed experiments
and analyzed data. JDS designed experiments, supervised the project and wrote
thepaper.Allauthorsdiscussedtheresultsandimplicationsandcommentedon the
paper at all stages.
SPL regulates the DNA damage response
A Kumar et al
10
Cell Death and Disease1. Lobrich M, Jeggo PA. The impact of a negligent G2/M checkpoint on genomic instability
and cancer induction. Nat Rev Cancer 2007; 7: 861–869.
2. Potapova T, Daum J, Byrd K, Gorbsky G. Fine tuning the cell cycle: activation of the Cdk1
inhibitory phosphorylation pathway during mitotic exit. Mol Biol Cell 2009; 20: 1737–1748.
3. Quintans J, Kilkus J, McShan C, Gottschalk A, Dawson G. Ceramide mediates the
apoptotic response of WEHI 231 cells to anti-immunoglobulin, corticosteroids and
irradiation. Biochem Biophys Res Commun 1994; 202: 710–714.
4. Lin X, Fuks Z, Kolesnick R. Ceramide mediates radiation-induced death of endothelium.
Crit Care Med 2000; 28: N87–N93.
5. Huang C, Ma W, Ding M, Bowden GT, Dong Z. Direct evidence for an important role of
sphingomyelinase in ultraviolet-induced activation of c-Jun N-terminal kinase. J Biol Chem
1997; 272: 27753–27757.
6. Sathishkumar S, Boyanovsky B, Karakashian AA, Rozenova K, Giltiay NV, Kudrimoti M
et al. Elevated sphingomyelinase activity and ceramide concentration in serum of patients
undergoing high dose spatially fractionated radiation treatment: implicationsfor endothelial
apoptosis. Cancer Biol Ther 2005; 4: 979–986.
7. Haimovitz-Friedman A, Kan C, Ehleiter D, Persaud R, McLoughlin M, Fuks Z et al. Ionizing
radiation acts on cellular membranes to generate ceramide and initiate apoptosis. JE x p
Med 1994; 180: 525–535.
8. Kolesnick R, Fuks Z. Radiation and ceramide-induced apoptosis. Oncogene 2003; 22:
5897–5906.
9. Rodriguez-Lafrasse C, Alphonse G, Aloy MT, Ardail D, Gerard JP, Louisot P et al.
Increasing endogenous ceramide using inhibitors of sphingolipid metabolism maximizes
ionizing radiation-induced mitochondrial injury and apoptotic cell killing. Int J Cancer 2002;
101: 589–598.
10. Santana P, Pena L, Haimovitz-Friedman A, Martin S, Green D, McLoughlin M et al. Acid
sphingomyelinase-deﬁcient human lymphoblasts and mice are defective in radiation-
induced apoptosis. Cell 1996; 86: 189–199.
11. Hwang D, Popat R, Bragdon C, O’Donnell KE, Sonis ST. Effects of ceramide inhibition on
experimental radiation-induced oral mucositis. Oral Surg Oral Med Oral Pathol Oral Radiol
Endod 2005; 100: 321–329.
12. Hla T. Physiological and pathological actions of sphingosine 1-phosphate. Semin Cell Dev
Biol 2004; 15: 513–520.
13. Otala M, Suomalainen L, Pentikainen M, Kovanen P, Tenhunen M, Erkkila K et al.
Protection from radiation-induced male germ cell loss by sphingosine-1-phosphate. Biol
Reprod 2004; 70: 759–767.
14. Morita Y, Perez GI, Paris F, Miranda SR, Ehleiter D, Haimovitz-Friedman A et al. Oocyte
apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by
sphingosine-1-phosphate therapy. Nat Med 2000; 6: 1109–1114.
15. Kumar A, Saba JD. Lyase to live by: sphingosine phosphate lyase as a therapeutic target.
Expert Opin Ther Targets 2009; 13: 1013–1025.
16. Oskouian B, Sooriyakumaran P, Borowsky A, Crans A, DIllard-Telm L, Tam Y et al.
Sphingosine-1-phosphate lyase potentiates apoptosis via p53- and p38-dependent
pathways and is downregulated in colon cancer. Proc Natl Acad Sci USA 2006; 103:
17384–17389.
17. Reiss U, Oskouian B, Zhou J, Gupta V, Sooriyakumaran P, Kelly S et al. Sphingosine-
phosphate lyase enhances stress-induced ceramide generation and apoptosis. J Biol
Chem 2004; 279: 1281–1290.
18. Min J, Stegner A, Alexander H, Alexander S. Overexpression of sphingosine-1-phosphate
lyase or inhibition of sphingosine kinase in Dictyostelium discoideum results in a selective
increaseinsensitivitytoplatinum-basedchemotherapydrugs.EukaryoticCell2004;3:795–805.
19. Colie S, Van Veldhoven PP, Kedjouar B, Bedia C, Albinet V, Sorli SC et al. Disruption of
sphingosine 1-phosphate lyase confers resistance to chemotherapy and promotes
oncogenesis through Bcl-2/Bcl-xL upregulation. Cancer Res 69: 9346–9353.
20. Castedo M, Perfettini J, Roumier T, Kroemer G. Cyclin-dependent kinase-1: linking
apoptosis to cell cycle and mitotic catastrophe. Cell Death Differ 2002; 9: 1287–1293.
21. MinJ, VanVeldhoven PP,Zhang L,Hanigan MH,Alexander H,AlexanderS. Sphingosine-
1-phosphate lyase regulates sensitivity of human cells to select chemotherapy drugs in a
p38-dependent manner. Mol Cancer Res 2005; 3: 287–296.
22. Kumar P, Miller AI, Polverini PJ. p38 MAPK mediates gamma-irradiation-induced
endothelial cell apoptosis, and vascular endothelial growth factor protects endothelial cells
through the phosphoinositide 3-kinase-Akt-Bcl-2 pathway. J Biol Chem 2004; 279:
43352–43360.
23. Chen C, LinC, Chang W, Huang W, Teng C, LinY. Ceramide induces p38 MAPK and JNK
activation through a mechanism involving a thioredoxin-interacting protein-mediated
pathway. Blood 2008; 111: 4365–4374.
24. Schwab S, Pereira J, Matloubian M, Xu Y, Huang Y, Cyster J. Lymphocyte sequestration
through S1P lyase inhibition an disruption of S1P gradients. Science 2005; 309:
1735–1739.
25. DeSimone JN, Bengtsson U, Wang X, Lao XY, Redpath JL, Stanbridge EJ. Complexity of
the mechanisms of initiation and maintenance of DNA damage-induced G2-phase arrest
and subsequent G1-phase arrest: TP53-dependent and TP53-independent roles. Radiat
Res 2003; 159: 72–85.
26. DiPaola RS. To arrest or not to G(2)-M Cell-cycle arrest : commentary re: AK Tyagi et al.,
Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-
induced growth inhibition, G(2)-M arrest, and apoptosis. Clin Cancer Res 8: 3512–3519,
2002. Clin Cancer Res 2002; 8: 3311–3314.
27. Burdak-Rothkamm S, Prise KM. New molecular targets in radiotherapy: DNA
damage signalling and repair in targeted and non-targeted cells. Eur J Pharmacol 2009;
625: 151–155.
28. Paris F, Perez G, Fuks Z, Haimovitz-Friedman A, Nguyen H, Bose M et al. Sphingosine-1-
phosphate preserves fertility in irradiated female mice without propagating genomic
damage in offspring. Nat Med 2002; 8: 901–902.
29. Schuchman E. Acid sphingomyelinase, cell membranes and human disease: lessons from
Niemann-Pick disease. FEBS Lett 2010; 584: 1895–1900.
30. Jenkins R, Canals D, Hannun Y. Roles and regulation of secretory and lysosomal acid
sphingomyelinase. Cell Signal 2009; 21: 836–846.
31. Vogel P, Donoviel M, Read R, Hansen G, Hazlewood J, Anderson S et al. Incomplete
inhibition of sphingosine 1-phosphate lyase modulates immune system function yet
prevents early lethality and non-lymphoid lesions. PLoS ONE 2009; 4: e4112.
32. Pitson SM, Moretti PA, Zebol JR, Lynn HE, Xia P, Vadas MA et al. Activation
of sphingosine kinase 1 by ERK1/2-mediated phosphorylation. EMBO J 2003; 22:
5491–5500.
33. Graham F, van der Eb A. A new technique for the assay of infectivity of human adenovirus
5 DNA. Virology 1973; 52: 456–467.
34. Tauseef M, Kini V, Knezevic N, Brannan M, Ramchandaran R, Fyrst H et al. Activation of
sphingosine kinase-1 reverses the increase in lung vascular permeability through
sphingosine-1-phosphate receptor signaling in endothelial cells. Circ Res 2008; 103:
1164–1172.
35. Paris F, Fuks Z, Kang A, Capodieci P, Juan G, Ehleiter D et al. Endothelial apoptosis
as the primary lesion initiating intestinal radiation damage in mice. Science 2001;
293: 293–297.
36. Bandhuvula P, Fyrst H, Saba J. A rapid ﬂuorescent assay for sphingosine-1-phosphate
lyase enzyme activity. J Lipid Res 2007; 48: 2769–2778.
Cell Death and Disease is an open-access journal
published by Nature Publishing Group. This work is
licensed under the Creative Commons Attribution-Noncommercial-No
DerivativeWorks3.0UnportedLicense. To view acopyof thislicense,
visit http://creativecommons.org/licenses/by-nc-nd/3.0/
Supplementary Information accompanies the paper on Cell Death and Disease website (http://www.nature.com/cddis)
SPL regulates the DNA damage response
A Kumar et al
11
Cell Death and Disease